- Open Access
Correction to: ECM1 regulates cell proliferation and trastuzumab resistance through activation of EGF-signaling
Breast Cancer Research volume 21, Article number: 45 (2019)
- The original article was published in Breast Cancer Research 2014 16:479
Correction to: Breast Cancer Res
After the publication of this work  errors were found in Figs. 1a and 5d. In the second column of Fig. 1a, an image from matrigel cultures of BT-474 wild type cells were mistakenly used for BT-474 TR shE cells. In Fig. 5d, the same blots were inserted for immunoprecipiation: HER3/Western blots: Mucin1 and immunoprecipitation Mucin1/Western blots: HER3. The corrected figures are shown below. We confirmed that the corrected figures do not affect conclusion and findings of the article. We sincerely apologize for the errors.
Lee KM, Nam K, Oh S, Lim J, Kim YP, Lee JW, Yu JH, Ahn SH, Kim SB, Noh DY, Lee T, Shin I. ECM1 regulates cell proliferation and trastuzumab resistance through activation of EGF-signaling. Breast Cancer Res. 2014;16(6):479–95.
About this article
Cite this article
Lee, K., Nam, K., Oh, S. et al. Correction to: ECM1 regulates cell proliferation and trastuzumab resistance through activation of EGF-signaling. Breast Cancer Res 21, 45 (2019). https://doi.org/10.1186/s13058-019-1106-3